AbbVie ending R&D deal with Alphabet-backed Calico (ABBV:NYSE)

Core Insights - AbbVie is ending a decade-long research and development collaboration with Calico Life Sciences, a company focused on age-related conditions and founded by Alphabet [4] Group 1 - The termination of the collaboration was reported by Stat News, citing internal emails from AbbVie [4]